Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Expert Opinion on Drug Safety|March 24, 2025
An updated safety review of Hidradenitis Suppurativa treatment optionsRuggero Cascio Ingurgio, Luciano Ibba, Angela Alfano, et al.Dermatology and Therapy|April 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World StudyPaola Facheris, Francesco Piscazzi, Giovanni Fiorillo, et al.Dermatology and Therapy|January 8, 2023
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week StudyLuigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.Dermatology Reports|July 3, 2024
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case reportMario Valenti, Andrea Cortese, Paola Facheris, et al.Dermatology and Therapy|April 9, 2026
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy FindingsFrancesco D'Oria, Francesco Piscazzi, Paola Facheris, et al.Journal of Cutaneous Pathology|November 27, 2019
Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvementPaola Facheris, Mario Valenti, Giulia Pavia, et al.Dermatology and Therapy|March 11, 2025
Chronic Hand Eczema (CHE): A Narrative ReviewGioele Ghezzi, Costanza Falcidia, Giovanni Paolino, et al.Clinical, Cosmetic and Investigational Dermatology|March 18, 2024
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic ReviewLuciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.Dermatologic Therapy|April 15, 2020
Brodalumab: A new way to inhibit IL-17 in psoriasisPaola Facheris, Mario Valenti, Giulia Pavia, et al.Dermatologic Therapy|November 25, 2021
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative studyAlessandra Narcisi, Mario Valenti, Andrea Cortese, et al.Pageof 8